(Circulation. 1996;94:6-9.)
© 1996 American Heart Association, Inc.
Articles |
Antioxidant Vitamin C Improves Endothelial Dysfunction in Chronic Smokers
the Medizinische Klinik III, Kardiologie, Universitat Freiburg, Germany.
Correspondence to Thomas Munzel, MD, Universitatskrankenhaus Eppendorf, Abteilung fur Kardiologie, Martinistr 55, 20246 Hamburg, FRG.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
Background Chronic smoking is associated with endothelial dysfunction, an early stage of atherosclerosis. It has been suggested that endothelial dysfunction may be a consequence of enhanced degradation of nitric oxide secondary to formation of oxygen-derived free radicals. To test this hypothesis, we investigated the effects of the antioxidant vitamin C on endothelium-dependent responses in chronic smokers.
Methods and Results Forearm blood flow responses to the endothelium-dependent vasodilator acetylcholine (7.5, 15, 30, and 60 µg/min) and the endothelium-independent vasodilator sodium nitroprusside (1, 3, and 10 µg/min) were measured by venous occlusion plethysmography in 10 control subjects and 10 chronic smokers. Drugs were infused into the brachial artery, and forearm blood flow was measured for each drug before and during concomitant intra-arterial infusion of the antioxidant vitamin C (18 mg/min). In control subjects, vitamin C had no effect on forearm blood flow in response to acetylcholine and sodium nitroprusside. In contrast, in chronic smokers the attenuated forearm blood flow responses to acetylcholine were markedly improved by concomitant administration of vitamin C, whereas the vasodilator responses to sodium nitroprusside were not affected.
Conclusions The present studies demonstrate that the antioxidant vitamin C markedly improves endothelium-dependent responses in chronic smokers. This observation supports the concept that endothelial dysfunction in chronic smokers is at least in part mediated by enhanced formation of oxygen-derived free radicals.
Key Words: smoking • endothelium • free radicals • antioxidants
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
Chronic cigarette smoking represents a major risk factor for the development of atherosclerosis associated with coronary and peripheral vascular disease.1 Cigarette smoke is known to contain a large number of oxidants, and it has been hypothesized that many of the adverse effects of smoking may result from oxidative damage to critical biological substances.2 Previous reports have demonstrated abnormal endothelial function in chronic smokers.3 4 Endothelial dysfunction, in turn, has been proposed to play a pathogenetic role in the initiation of vascular disease.5 Although smoking-induced endothelial dysfunction is very likely multifactorial, more recent clinical and experimental observations strongly point to a potential role of oxygen-derived free radicals in mediating this phenomenon.6 7
Vitamin C is a strong reducing agent known to act as an antioxidant in vitro and in vivo.8 Vitamin C very effectively protects lipids in human plasma against peroxidative damage by scavenging oxygen-derived free radicals.9 In addition, epidemiological studies have shown that smokers have a significantly lower plasma level of vitamin C compared with nonsmokers.10
Therefore, the present study was designed to investigate whether the antioxidant vitamin C can improve endothelium-dependent vasodilation in chronic smokers.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
Subjects
Ten control subjects (mean age, 51±3 years) and 10 chronic smokers (mean age, 55±3 years) were studied (Table
). Chronic smokers were included if they had a history of 20 or more pack-years (1 pack-year defined as smoking 20 cigarettes per day for 1 year or the equivalent). No participant had a history of hypercholesterolemia, arterial hypertension, diabetes mellitus, or any other systemic disease predisposing them to endothelial dysfunction. Further exclusion criteria were current use of antioxidants or vasoactive medications. All participants gave written informed consent, and the study protocol was approved by the local Ethics Committee of the University of Freiburg.
|
Study Protocol
All studies were performed in a temperature-controlled room in the postabsorptive state. Under local anesthesia and sterile conditions, a 20-gauge polyethylene catheter was inserted into the brachial artery of the nondominant arm for infusion of drugs. Forearm blood flow was measured by venous occlusion plethysmography as recently described.3 Systolic, diastolic, and mean arterial pressures and heart rate were determined at the contralateral arm with a Dinamap (845 oscillometric) blood pressure recorder. Forearm vascular resistance was calculated as the ratio of mean blood pressure to forearm blood flow and expressed as units reflecting mm Hg·mL-1·min-1·100 mL tissue-1.
Baseline measurements were obtained during intra-arterial infusion of 0.9% saline at a rate of 1.66 mL/min. To assess endothelium-dependent vasodilation, acetylcholine chloride was administered at increasing concentrations (7.5, 15, 30, and 60 µg/min). Sodium nitroprusside was infused as an endothelium-independent vasodilator (1, 3, and 10 µg/min). Each concentration of acetylcholine and sodium nitroprusside was infused for a 5-minute period. Forearm blood flow was measured during the last 2 minutes of the infusion period.
After another rest period of at least 40 minutes, vitamin C (sodium ascorbate, Merck) was administered intra-arterially to test the effects of vitamin C on forearm blood flow response to acetylcholine and sodium nitroprusside. Concentration and infusion rate of vitamin C (total dose about 1 g) was chosen to reach local forearm concentrations, which have been demonstrated to inhibit superoxide anion-mediated lipid peroxidation.11 Moreover, a similar concentration of vitamin C has been reported recently to improve endothelial function in patients with diabetes mellitus.12
We also measured plasma cholinesterase activity in both groups by using a cholinesterase activity assay (kinetic color test, Merck) to address a potentially confounding influence of cholinesterase to our results (normal range, 2300 to 7200 U/L).
Statistical Analysis
All values are reported as mean±SEM. Group comparisons with respect to baseline characteristics were performed by unpaired t test. To test for differences in the overall dose-response relationship in response to acetylcholine and sodium nitroprusside with and without vitamin C, a two-way ANOVA for repeated measures was applied. Statistical significance was accepted at a level of 
=5%.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
Patient Characteristics
The clinical characteristics of the study groups are provided in the Table
. All subjects included in this study were men. There was no difference in terms of age, blood pressure, lipid profile, forearm length, forearm volume, and cholinesterase activity. Chronic smokers had a history of 39±7 pack-years. The basal forearm blood flow and forearm vascular resistance were similar in both groups. In a separate group (n=4 smokers), the effect of vitamin C on cholinesterase activity was measured. Cholinesterase activity before and after administration of vitamin C (total dose of 1 g) was virtually identical (5054±193 versus 5037±199 U/L).
Effects of Intra-arterial Acetylcholine and Sodium Nitroprusside on Forearm Blood Flow in Control Subjects and Chronic Smokers
Increasing concentrations of acetylcholine dose-dependently increased forearm blood flow in control subjects from 3.2±0.2 to maximally 19.9±0.5 mL·min-1·100 mL-1 and decreased forearm vascular resistance from 29.7±2.4 to maximally 4.6±0.1 mL·min-1·100 mL-1. The vasodilator responses to acetylcholine were significantly (P<.05) attenuated in chronic smokers compared with nonsmoking control subjects (increase maximally from 3.0±0.28 to 12.2±1.1 mL·min-1·100 mL-1). In contrast, the increases in forearm blood flow in response to the endothelium-independent nitrovasodilator sodium nitroprusside were comparable in both groups (Figs 1 and 2).
|
|
Effects of Vitamin C on Forearm Blood Flow Responses to Acetylcholine and Nitroprusside
In control subjects, concomitant infusion of vitamin C did not alter responses to either acetylcholine or nitroprusside. In contrast, in chronic smokers vitamin C markedly improved endothelium-dependent vasodilation in response to acetylcholine (P<.05) while having no effect on vasodilation induced by the endothelium-independent vasodilator sodium nitroprusside (Figs 1 and 2). Since we did not observe significant changes in mean arterial pressure, changes in forearm vascular resistance mirrored changes in forearm blood flow.
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
The present studies demonstrate that impaired endothelium-dependent vasodilation in chronic smokers can be markedly improved by acute concomitant administration of the antioxidant vitamin C. This observation strongly supports the concept that increased production and/or activity of oxygen-derived free radicals contribute to endothelial dysfunction in chronic smokers.
With these studies we found a marked attenuation of endothelium-dependent vasodilation in forearm resistance vessels in chronic smokers compared with healthy control subjects. This observation is in agreement with previous observations showing in chronic smokers blunted endothelium-dependent vasodilation of large and small arteries in response to pharmacological (such as acetylcholine3 ) and/or mechanical stimuli (such as shear stress4 ). The precise mechanism of smoking-related endothelial dysfunction is not well understood but is probably multifactorial. Blunted responses to endothelium-dependent vasodilators may be explained in general by a nonspecific attenuation of the vasodilator capacity of the vessel at the vascular smooth muscle level, by diminished nitric oxide formation within endothelial cells, or may be secondary to enhanced degradation of nitric oxide as the result of endothelial and/or smooth muscle production of oxygen-derived free radicals.
A nonspecific attenuation of the vasodilator capacity of forearm resistance arteries is not very likely, since the vasodilator responses to the endothelium-independent nitrovasodilator nitroprusside were preserved. We also can exclude a confounding influence of the cholinesterase activity on our results, since the cholinesterase activity did not differ between smokers and nonsmokers and vitamin C per se had no stimulatory effect on the cholinesterase activity (see "Results").
More recent experimental and clinical data strongly demonstrate evidence for increased oxidative stress being responsible for endothelial dysfunction in chronic smokers.6 7 Cigarette smoke (especially the gas phase) contains large amounts of free radicals and prooxidants such as NO, NO2, peroxinitrite, transition metals, phenols, epoxides, and nitrosamines.2 The particulate phase contains high concentrations of lipophilic quinones, which in biological systems undergo redox cycling to produce oxidant species such as O2-· and H2O2.2 These two compounds can form the highly reactive OH· radical at site-specific locations where catalytic iron is available.2 Furthermore, O2-· from cigarette smoke may reach the vascular endothelium and can then react with NO·,13 reducing the vasoactive levels of NO· and diminishing the response to endothelium-dependent vasodilators via formation of peroxynitrite anion (ONOO-), a highly reactive intermediate with strong cytotoxic potency.13 14 Thus, the damaging free radicals in cigarette smoke may cause either direct arterial wall injury or more may initiate and/or accelerate secondary processes including depletion of antioxidants (such as vitamin C or vitamin E9 ), protein peroxidation,15 and activation of phagocyte-platelet-endothelial cell interactions.16 17 Oxygen-derived free radicals within the vasculature may initiate a vicious cycle by oxidizing lipids or lipoprotein(a), which in turn may inhibit endothelium-dependent vasodilation directly18 or indirectly by the formation of superoxide anions.19 Recently, we demonstrated a close inverse relationship between antibody titers against oxidized LDL and acetylcholine-induced changes in forearm blood flow in chronic smokers, suggesting that oxidized LDL may be involved in endothelial dysfunction in chronic smokers.3 Further imbalance between prooxidants and antioxidants within the vasculature also may be operative in smokers, since plasma levels of vitamin C are in general lower compared with healthy control subjects,10 a phenomenon that appears to reflect increased metabolism as the result of oxidant load rather than decreased food intake.20
In the present study, the acute administration of the antioxidant vitamin C markedly improved endothelium-mediated vasodilatation in chronic smokers while having no significant effects on endothelium-independent vasodilation induced by sodium nitroprusside. This finding strongly suggests that the antioxidant vitamin C decreases oxidative stress within the vasculature of chronic smokers by directly scavenging oxygen-derived free radicals11 such as superoxide anions or hydroxyl radicals. Further antioxidant mechanisms of vitamin C may include an inhibition of smoke-induced leukocyte adhesion and aggregation to endothelial cells,21 protection from oxidized LDL-induced leukocyte adhesion to vascular endothelium, and protection of LDL against atherogenic modification9 22 (see Fig 3A). The chemical reaction between superoxide and vitamin C is a protonation of superoxide leading to the perhydroxyl radical (HO2· [Reference 23]) or eventually to H2O2 (Reference 24) (see Fig 3B).
|
|
Conclusions |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
The present study demonstrates that acute administration of vitamin C almost completely reverses endothelial dysfunction in chronic smokers. Whether or not daily oral intake of vitamin C may limit the cardiovascular consequences of chronic smoking requires further clinical investigation.
Received April 15, 1996; accepted May 7, 1996.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
1. Sackett DL, Gibson RW, Bross IDJ, Pickren JW. Relation between aortic atherosclerosis and the use of cigarettes and alcohol: an autopsy study. N Engl J Med.. 1968;279:1413-1420.
2. Church DF, Pryor WA. Free radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect.. 1985;64:111-126.[Medline] [Order article via Infotrieve]
3. Heitzer T, Yla-Herttuala S, Luoma J, Kurz S, Munzel T, Just H, Olschewski M, Drexler H. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation.. 1996;93:1347-1353.
4.
Zeiher AM, Schachinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation.. 1995;92:1094-1100.
5. Cohen R. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis.. 1995;38:105-128.[Medline] [Order article via Infotrieve]
6.
Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med.. 1995;332:1198-1203.
7.
Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol.. 1994;266:H874-H880.
8. Frei B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med.. 1994;97:5S-13S.[Medline] [Order article via Infotrieve]
9. Frei B, Forte TM, Ames BN, Cross CE. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma: protective effects of ascorbic acid. Biochem J.. 1991;277:133-138.
10.
Schectman G, Byrd JC, Gruchow HW. The influence of smoking on vitamin C status in adults. Am J Public Health.. 1989;79:158-162.
11.
Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A.. 1989;86:6377-6381.
12. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest.. 1996;97:22-28.[Medline] [Order article via Infotrieve]
13. Radi R, Beckman JW, Bush KM, Freeman BA. Peroxynitrite induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys.. 1991;288:481-487.[Medline] [Order article via Infotrieve]
14.
White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey MM. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci U S A.. 1994;91:1044-1048.
15. Reznick AZ, Cross CE, Hu ML, Suzuki YJ, Khwaja S, Safadi A, Motchnik PA, Packer L, Halliwell B. Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation. Biochem J.. 1992;286:607-611.
16. Lehr HA, Kress E, Menger MD, Friedl HP, Hubner C, Arfors KE, Messmer K. Cigarette smoke elicits leukocyte adhesion to endothelium in hamsters: inhibition by Cu/Zn SOD. Free Radic Biol Med.. 1993;14:573-581.[Medline] [Order article via Infotrieve]
17.
Blache D. Involvement of hydrogen and lipid peroxides in acute tobacco smoking-induced platelet hyperactivity. Am J Physiol.. 1995;268:H679-H685.
18.
Galle J, Mulsch A, Busse R, Bassenge E. Effects of native and oxidized low-density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb.. 1991;11:198-203.
19.
Galle J, Bengen J, Schollmeyer P, Wanner C. Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a): role of oxygen-derived radicals. Circulation.. 1995;92:1582-1589.
20. Duthie GG, Wahle KJ. Smoking, antioxidants, essential fatty acids and coronary heart disease. Biochem Soc Trans.. 1990;18:1051-1054.[Medline] [Order article via Infotrieve]
21.
Lehr HA, Frei B, Arfors KE. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to the endothelium in vivo. Proc Natl Acad Sci U S A.. 1994;91:7688-7692.
22.
Retsky KL, Freeman MW, Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. J Biol Chem.. 1993;268:1304-1309.
23. Bisby RH, Ahmed S, Cundall RB. Repair of amino acid radicals by vitamin E analogue. Biochem Biophys Res Commun.. 1984;119:245-250.[Medline] [Order article via Infotrieve]
24. Cabelli DE, Bielski BHJ. Kinetics and mechanism for the oxidation of ascorbic acid/ascorbate by HO2/O2 radicals: a pulse radiolysis and stopped-flow photolysis study. J Phys Chem.. 1983;87:1809-1812. File paper.
This article has been cited by other articles:
 |
|
 |
|
  T. K. Rudolph, V. Rudolph, and S. Baldus Contribution of Myeloperoxidase to Smoking-dependent Vascular Inflammation Proceedings of the ATS, December 1, 2008; 5(8): 820 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Siekmeier, C. Steffen, and W. Marz Role of Oxidants and Antioxidants in Atherosclerosis: Results of In Vitro and In Vivo Investigations Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2007; 12(4): 265 - 282. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Yang, C. B. Ambrosone, C.-C. Hong, J. Ahn, C. Rodriguez, M. J. Thun, and E. E. Calle Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer Carcinogenesis, June 1, 2007; 28(6): 1247 - 1253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Stadler, J. Eggermann, S. Voo, A. Kranz, and J. Waltenberger Smoking-Induced Monocyte Dysfunction Is Reversed by Vitamin C Supplementation In Vivo Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 120 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Forstermann and T. Munzel Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace Circulation, April 4, 2006; 113(13): 1708 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S G. Wannamethee, G. D. Lowe, A. Rumley, K R. Bruckdorfer, and P. H Whincup Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis Am. J. Clinical Nutrition, March 1, 2006; 83(3): 567 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Fang, H. Sun, D. M. Arrick, and W. G. Mayhan Inhibition of NADPH oxidase improves impaired reactivity of pial arterioles during chronic exposure to nicotine J Appl Physiol, February 1, 2006; 100(2): 631 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Tousoulis, C Xenakis, C Tentolouris, G Davies, C Antoniades, T Crake, and C Stefanadis Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina Heart, October 1, 2005; 91(10): 1319 - 1323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Berger, C. Hesse, C. Dehnert, H. Siedler, P. Kleinbongard, H. J. Bardenheuer, M. Kelm, P. Bartsch, and W. E. Haefeli Hypoxia Impairs Systemic Endothelial Function in Individuals Prone to High-Altitude Pulmonary Edema Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 763 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Munzel, A. Daiber, V. Ullrich, and A. Mulsch Vascular Consequences of Endothelial Nitric Oxide Synthase Uncoupling for the Activity and Expression of the Soluble Guanylyl Cyclase and the cGMP-Dependent Protein Kinase Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1551 - 1557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V.-P. Valkonen, T.-P. Tuomainen, and R. Laaksonen DDAH gene and cardiovascular risk Vascular Medicine, July 1, 2005; 10(1_suppl): S45 - S48. [Abstract] [PDF]
|
|
|
|
|
|
T. Heitzer, S. Baldus, Y. von Kodolitsch, V. Rudolph, and T. Meinertz Systemic Endothelial Dysfunction as an Early Predictor of Adverse Outcome in Heart Failure Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1174 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V.-P. Valkonen, T.-P. Tuomainen, and R. Laaksonen DDAH gene and cardiovascular risk Vascular Medicine, May 1, 2005; 10(2_suppl): S45 - S48. [Abstract] [PDF]
|
|
|
|
|
|
D. D. Gutterman, H. Miura, and Y. Liu Redox Modulation of Vascular Tone: Focus of Potassium Channel Mechanisms of Dilation Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 671 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Takase, H. Etsuda, Y. Matsushima, M. Ayaori, H. Kusano, A. Hamabe, A. Uehata, F. Ohsuzu, M. Ishihara, and A. Kurita Effect of Chronic Oral Supplementation with Vitamins on the Endothelial Function in Chronic Smokers Angiology, November 1, 2004; 55(6): 653 - 660. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Beckman, J. K. Liao, S. Hurley, L. A. Garrett, D. Chui, D. Mitra, and M. A. Creager Atorvastatin Restores Endothelial Function in Normocholesterolemic Smokers Independent of Changes in Low-Density Lipoprotein Circ. Res., July 23, 2004; 95(2): 217 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Sim, C. Farquharson, and A. D Struthers Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man Journal of Renin-Angiotensin-Aldosterone System, June 1, 2004; 5(2): 84 - 88. [Abstract] [PDF]
|
|
|
|
 |
|
 J. A. Ambrose and R. S. Barua The pathophysiology of cigarette smoking and cardiovascular disease: An update J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1731 - 1737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S Hampl, C. A. Taylor, and C. S. Johnston Vitamin C Deficiency and Depletion in the United States: The Third National Health and Nutrition Examination Survey, 1988 to 1994 Am J Public Health, May 1, 2004; 94(5): 870 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Eskurza, K. D. Monahan, J. A. Robinson, and D. R. Seals Ascorbic acid does not affect large elastic artery compliance or central blood pressure in young and older men Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1528 - H1534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Alp and K. M. Channon Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 413 - 420. [Abstract] [Full Text]
|
|
|
|
|
|
W S Waring, S H Adwani, O Breukels, D J Webb, and S R J Maxwell Hyperuricaemia does not impair cardiovascular function in healthy adults Heart, February 1, 2004; 90(2): 155 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Wimpissinger, H. Resch, F. Berisha, G. Weigert, K. Polak, and L. Schmetterer Effects of Isometric Exercise on Subfoveal Choroidal Blood Flow in Smokers and Nonsmokers Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4859 - 4863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Schindler, E. U. Nitzsche, T. Munzel, M. Olschewski, I. Brink, M. Jeserich, M. Mix, P. T. Buser, M. Pfisterer, U. Solzbach, et al. Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: Contrasting myocardial blood flow responses to short- and long-term vitamin C administration J. Am. Coll. Cardiol., September 3, 2003; 42(5): 814 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K Heilbronn and E. Ravussin Calorie restriction and aging: review of the literature and implications for studies in humans Am. J. Clinical Nutrition, September 1, 2003; 78(3): 361 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kuzkaya, N. Weissmann, D. G. Harrison, and S. Dikalov Interactions of Peroxynitrite, Tetrahydrobiopterin, Ascorbic Acid, and Thiols: IMPLICATIONS FOR UNCOUPLING ENDOTHELIAL NITRIC-OXIDE SYNTHASE J. Biol. Chem., June 13, 2003; 278(25): 22546 - 22554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sciacqua, M. Candigliota, R. Ceravolo, A. Scozzafava, F. Sinopoli, A. Corsonello, G. Sesti, and F. Perticone Weight Loss in Combination With Physical Activity Improves Endothelial Dysfunction in Human Obesity Diabetes Care, June 1, 2003; 26(6): 1673 - 1678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Reaven and P. S. Tsao Insulin resistance and compensatory hyperinsulinemia: The key player between cigarette smoking and cardiovascular disease? J. Am. Coll. Cardiol., March 19, 2003; 41(6): 1044 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Drossos, I. K. Toumpoulis, D. G. Katritsis, J. P. A. Ioannidis, P. Kontogiorgi, E. Svarna, and C. E. Anagnostopoulos Is vitamin C superior to diltiazem for radial artery vasodilation in patients awaiting coronary artery bypass grafting? J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 330 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Fang, H. Sun, and W. G. Mayhan Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H528 - H534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Chenevard, D. Hurlimann, M. Bechir, F. Enseleit, L. Spieker, M. Hermann, W. Riesen, S. Gay, R. E. Gay, M. Neidhart, et al. Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease Circulation, January 28, 2003; 107(3): 405 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.M. Fennessy, D.S. Moneley, J.H. Wang, C.J. Kelly, and D.J. Bouchier-Hayes Taurine and Vitamin C Modify Monocyte and Endothelial Dysfunction in Young Smokers Circulation, January 28, 2003; 107(3): 410 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. V. d'Uscio, S. Milstien, D. Richardson, L. Smith, and Z. S. Katusic Long-Term Vitamin C Treatment Increases Vascular Tetrahydrobiopterin Levels and Nitric Oxide Synthase Activity Circ. Res., January 10, 2003; 92(1): 88 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Singh, J. Graves, P. D Taylor, R. J MacAllister, and D. R.J Singer Effects of a 'healthy' diet and of acute and long-term vitamin C on vascular function in healthy older subjects Cardiovasc Res, October 1, 2002; 56(1): 118 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. T. McGrath, L. Dixon, D. R. Morgan, and G. E. McVeigh Production of 8-epi prostaglandin F2{alpha} in human platelets during administration of organic nitrates J. Am. Coll. Cardiol., August 21, 2002; 40(4): 820 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Maas, E. Schwedhelm, J. Albsmeier, and R. H Boger The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function Vascular Medicine, August 1, 2002; 7(3): 213 - 225. [Abstract] [PDF]
|
|
|
|
|
|
M. Komatsu, T. Kawagishi, M. Emoto, T. Shoji, A. Yamada, K. Sato, M. Hosoi, and Y. Nishizawa ecNOS gene polymorphism is associated with endothelium-dependent vasodilation in Type 2 diabetes Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H557 - H561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tsuchiya, A. Asada, E. Kasahara, E. F. Sato, M. Shindo, and M. Inoue Smoking a Single Cigarette Rapidly Reduces Combined Concentrations of Nitrate and Nitrite and Concentrations of Antioxidants in Plasma Circulation, March 12, 2002; 105(10): 1155 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Toth, Z. Kukor, and S. Valent Chemical stabilization of tetrahydrobiopterin by L-ascorbic acid: contribution to placental endothelial nitric oxide synthase activity Mol. Hum. Reprod., March 1, 2002; 8(3): 271 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Neunteufl, S. Heher, K. Kostner, G. Mitulovic, S. Lehr, G. Khoschsorur, R. W. Schmid, G. Maurer, and T. Stefenelli Contribution of nicotine to acute endothelial dysfunction in long-term smokers J. Am. Coll. Cardiol., January 16, 2002; 39(2): 251 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Heitzer, T. Schlinzig, K. Krohn, T. Meinertz, and T. Munzel Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease Circulation, November 27, 2001; 104(22): 2673 - 2678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. A. Witte, A. L. Clark, and J. G. F. Cleland Chronic heart failure and micronutrients J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1765 - 1774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A Brown and F. B Hu Dietary modulation of endothelial function: implications for cardiovascular disease Am. J. Clinical Nutrition, April 1, 2001; 73(4): 673 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Grossmann, D. Dobrev, H. M. Himmel, U. Ravens, and W. Kirch Ascorbic Acid-Induced Modulation of Venous Tone in Humans Hypertension, March 1, 2001; 37(3): 949 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Calles-Escandon and M. Cipolla Diabetes and Endothelial Dysfunction: A Clinical Perspective Endocr. Rev., February 1, 2001; 22(1): 36 - 52. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. Perticone, R. Ceravolo, M. Candigliota, G. Ventura, S. Iacopino, F. Sinopoli, and P. L. Mattioli Obesity and Body Fat Distribution Induce Endothelial Dysfunction by Oxidative Stress: Protective Effect of Vitamin C Diabetes, January 1, 2001; 50(1): 159 - 165. [Abstract] [Full Text]
|
|
|
|
|
|
A. Natali, A. M. Sironi, E. Toschi, S. Camastra, G. Sanna, A. Perissinotto, S. Taddei, and E. Ferrannini Effect of Vitamin C on Forearm Blood Flow and Glucose Metabolism in Essential Hypertension Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2401 - 2406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kaufmann, T. Gnecchi-Ruscone, M. di Terlizzi, K. P. Schafers, T. F. Luscher, and P. G. Camici Coronary Heart Disease in Smokers : Vitamin C Restores Coronary Microcirculatory Function Circulation, September 12, 2000; 102(11): 1233 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Tomasian, J. F. Keaney Jr., and J. A. Vita Antioxidants and the bioactivity of endothelium-derived nitric oxide Cardiovasc Res, August 18, 2000; 47(3): 426 - 435. [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Halimi and A. Mimran Renal effects of smoking: potential mechanisms and perspectives Nephrol. Dial. Transplant., July 1, 2000; 15(7): 938 - 940. [Full Text] [PDF]
|
|
|
|
|
|
C. M Loria, M. J Klag, L. E Caulfield, and P. K Whelton Vitamin C status and mortality in US adults Am. J. Clinical Nutrition, July 1, 2000; 72(1): 139 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A Riemersma, K. F Carruthers, R. A Elton, and K. A. Fox Vitamin C and the risk of acute myocardial infarction Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1181 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. T. Raitakari, M. R. Adams, R. J. McCredie, K. A. Griffiths, R. Stocker, and D. S. Celermajer Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1616 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Szekacs, W. Dachman, and Z. Vajo Alterations of Venous Drug Reactivity in Humans: Acquired and Genetic Factors Angiology, May 1, 2000; 51(5): 361 - 366. [Abstract] [PDF]
|
|
|
|
|
|
T. Heitzer, C. Brockhoff, B. Mayer, A. Warnholtz, H. Mollnau, S. Henne, T. Meinertz, and T. Munzel Tetrahydrobiopterin Improves Endothelium-Dependent Vasodilation in Chronic Smokers : Evidence for a Dysfunctional Nitric Oxide Synthase Circ. Res., February 4, 2000; 86 (2): e36 - e41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Neunteufl, U. Priglinger, S. Heher, M. Zehetgruber, G. Soregi, S. Lehr, K. Huber, G. Maurer, F. Weidinger, and K. Kostner Effects of vitamin E on chronic and acute endothelial dysfunction in smokers J. Am. Coll. Cardiol., February 1, 2000; 35(2): 277 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Frei On the Role of Vitamin C and Other Antioxidants in Atherogenesis and Vascular Dysfunction Experimental Biology and Medicine, December 1, 1999; 222(3): 196 - 204. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Jeserich, T. Schindler, M. Olschewski, M. Unmussig, H. Just, and U. Solzbach Vitamin C improves endothelial function of epicardial coronary arteries in patients with hypercholesterolaemia or essential hypertension--assessed by cold pressor testing Eur. Heart J., November 2, 1999; 20(22): 1676 - 1680. [Abstract] [PDF]
|
|
|
|
|
|
T. J. Anderson Assessment and treatment of endothelial dysfunction in humans J. Am. Coll. Cardiol., September 1, 1999; 34(3): 631 - 638. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tousoulis, G. Davies, and P. Toutouzas Vitamin C Increases Nitric Oxide Availability in Coronary Atherosclerosis Ann Intern Med, July 20, 1999; 131(2): 156 - 157. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ramasamy, G. R. Drummond, J. Ahn, M. Storek, J. Pohl, S. Parthasarathy, and D. G. Harrison Modulation of Expression of Endothelial Nitric Oxide Synthase by Nordihydroguaiaretic Acid, a Phenolic Antioxidant in Cultured Endothelial Cells Mol. Pharmacol., July 1, 1999; 56(1): 116 - 123. [Abstract] [Full Text]
|
|
|
|
|
|
N. Gokce, J. F. Keaney Jr, B. Frei, M. Holbrook, M. Olesiak, B. J. Zachariah, C. Leeuwenburgh, J. W. Heinecke, and J. A. Vita Long-Term Ascorbic Acid Administration Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease Circulation, June 29, 1999; 99(25): 3234 - 3240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C Carr and B. Frei Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans Am. J. Clinical Nutrition, June 1, 1999; 69(6): 1086 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wever, P. Boer, M. Hijmering, E. Stroes, M. Verhaar, J. Kastelein, K. Versluis, F. Lagerwerf, H. van Rijn, H. Koomans, et al. Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1168 - 1172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Mayhan and G. M. Sharpe Chronic exposure to nicotine alters endothelium-dependent arteriolar dilatation: effect of superoxide dismutase J Appl Physiol, April 1, 1999; 86(4): 1126 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Newby, R. A. Wright, C. Labinjoh, C. A. Ludlam, K. A. A. Fox, N. A. Boon, and D. J. Webb Endothelial Dysfunction, Impaired Endogenous Fibrinolysis, and Cigarette Smoking : A Mechanism for Arterial Thrombosis and Myocardial Infarction Circulation, March 23, 1999; 99(11): 1411 - 1415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Heller, F. Munscher-Paulig, R. Grabner, and U. Till L-Ascorbic Acid Potentiates Nitric Oxide Synthesis in Endothelial Cells J. Biol. Chem., March 19, 1999; 274(12): 8254 - 8260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Heitzer, S. Y. Herttuala, E. Wild, J. Luoma, and H. Drexler Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both J. Am. Coll. Cardiol., February 1, 1999; 33(2): 499 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Perticone, R. Ceravolo, R. Maio, G. Ventura, S. Iacopino, G. Cuda, P. Mastroroberto, M. Chello, and P. L. Mattioli Calcium antagonist isradipine improves abnormal endothelium-dependent vasodilation in never treated hypertensive patients Cardiovasc Res, January 1, 1999; 41(1): 299 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Motoyama, H. Kawano, K. Kugiyama, O. Hirashima, M. Ohgushi, R. Tsunoda, Y. Moriyama, Y. Miyao, M. Yoshimura, H. Ogawa, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1672 - 1679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Jackson, A. Xu, J. A. Vita, and J. F. Keaney Jr Ascorbate Prevents the Interaction of Superoxide and Nitric Oxide Only at Very High Physiological Concentrations Circ. Res., November 2, 1998; 83(9): 916 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Mayhan and G. M. Sharpe Superoxide dismutase restores endothelium-dependent arteriolar dilatation during acute infusion of nicotine J Appl Physiol, October 1, 1998; 85(4): 1292 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Mays, T. Ripple, M. T. Eginton, G. R. Seabrook, R. A. Cambria, J. B. Towne, and J. A. Freischlag Smoking Cessation Reverses Arterial Endothelium-Dependent Relaxation Injury Vascular and Endovascular Surgery, September 1, 1998; 32(5): 407 - 413. [Abstract] [PDF]
|
|
|
|
|
|
H. Moreno Jr., S. Chalon, A. Urae, O. Tangphao, A. K. Abiose, B. B. Hoffman, and T. F. Blaschke Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H1040 - H1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Minuz, G. Andrioli, M. Degan, S. Gaino, R. Ortolani, R. Tommasoli, V. Zuliani, A. Lechi, and C. Lechi The F2-Isoprostane 8-Epiprostaglandin F2{alpha} Increases Platelet Adhesion and Reduces the Antiadhesive and Antiaggregatory Effects of NO Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1248 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Cannon III Role of nitric oxide in cardiovascular disease: focus on the endothelium Clin. Chem., August 1, 1998; 44(8): 1809 - 1819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Campisi, J. Czernin, H. Schoder, J. W. Sayre, F. D. Marengo, M. E. Phelps, and H. R. Schelbert Effects of Long-term Smoking on Myocardial Blood Flow, Coronary Vasomotion, and Vasodilator Capacity Circulation, July 14, 1998; 98(2): 119 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kugiyama, T. Motoyama, O. Hirashima, M. Ohgushi, H. Soejima, K. Misumi, H. Kawano, Y. Miyao, M. Yoshimura, H. Ogawa, et al. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina J. Am. Coll. Cardiol., July 1, 1998; 32(1): 103 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Thorne, M. J. Mullen, P. Clarkson, A. E. Donald, and J. E. Deanfield Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine J. Am. Coll. Cardiol., July 1, 1998; 32(1): 110 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Taddei, A. Virdis, L. Ghiadoni, A. Magagna, and A. Salvetti Vitamin C Improves Endothelium-Dependent Vasodilation by Restoring Nitric Oxide Activity in Essential Hypertension Circulation, June 9, 1998; 97(22): 2222 - 2229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Cines, E. S. Pollak, C. A. Buck, J. Loscalzo, G. A. Zimmerman, R. P. McEver, J. S. Pober, T. M. Wick, B. A. Konkle, B. S. Schwartz, et al. Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders Blood, May 15, 1998; 91(10): 3527 - 3561. [Full Text] [PDF]
|
|
|
|
|
|
W. G. Mayhan and G. M. Sharpe Nicotine impairs histamine-induced increases in macromolecular efflux: role of oxygen radicals J Appl Physiol, May 1, 1998; 84(5): 1589 - 1595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sugiyama, K. Kugiyama, M. Ohgushi, T. Matsumura, Y. Ota, H. Doi, N. Ogata, H. Oka, and H. Yasue Supersensitivity of atherosclerotic artery to constrictor effect of cigarette smoke extract Cardiovasc Res, May 1, 1998; 38(2): 508 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita Randomized, Double-Blind, Placebo-Controlled Study of Ascorbate on the Preventive Effect of Nitrate Tolerance in Patients With Congestive Heart Failure Circulation, March 10, 1998; 97(9): 886 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T Powell Vascular damage from smoking: disease mechanisms at the arterial wall Vascular Medicine, February 1, 1998; 3(1): 21 - 28. [Abstract] [PDF]
|
|
|
|
 |
|
 M. P. Reilly, J. A. Lawson, and G. A. FitzGerald Eicosanoids and Isoeicosanoids: Indices of Cellular Function and Oxidant Stress J. Nutr., February 1, 1998; 128(2): 434 - 434. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. D. Plotnick, M. C. Corretti, and R. A. Vogel Effect of Antioxidant Vitamins on the Transient Impairment of Endothelium--Dependent Brachial Artery Vasoactivity Following a Single High-Fat Meal JAMA, November 26, 1997; 278(20): 1682 - 1686. [Abstract] [PDF]
|
|
|
|
|
|
T. Motoyama, H. Kawano, K. Kugiyama, O. Hirashima, M. Ohgushi, M. Yoshimura, H. Ogawa, and H. Yasue Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: effect of vitamin C Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1644 - H1650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Solzbach, B. Hornig, M. Jeserich, and H. Just Vitamin C Improves Endothelial Dysfunction of Epicardial Coronary Arteries in Hypertensive Patients Circulation, September 2, 1997; 96(5): 1513 - 1519. [Abstract] [Full Text]
|
|
|
|
|
|
H. H. Ting, F. K. Timimi, E. A. Haley, M.-A. Roddy, P. Ganz, and M. A. Creager Vitamin C Improves Endothelium-Dependent Vasodilation in Forearm Resistance Vessels of Humans With Hypercholesterolemia Circulation, June 17, 1997; 95(12): 2617 - 2622. [Abstract] [Full Text]
|
|
|
|
|
|
M. Skatchkov, L.L. Larina, A.A. Larin, N. Fink, and E. Bassenge Urinary Nitrotyrosine Content as a Marker of Peroxynitrite-induced Tolerance to Organic Nitrates Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(2): 85 - 96. [Abstract] [PDF]
|
|
|
|
|
|
A. Huang, J. A. Vita, R. C. Venema, and J. F. Keaney Jr. Ascorbic Acid Enhances Endothelial Nitric-oxide Synthase Activity by Increasing Intracellular Tetrahydrobiopterin J. Biol. Chem., June 2, 2000; 275(23): 17399 - 17406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Heller, A. Unbehaun, B. Schellenberg, B. Mayer, G. Werner-Felmayer, and E. R. Werner L-Ascorbic Acid Potentiates Endothelial Nitric Oxide Synthesis via a Chemical Stabilization of Tetrahydrobiopterin J. Biol. Chem., January 5, 2001; 276(1): 40 - 47. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||